Posts

Windward Bio files for Nasdaq IPO to fund clinical programs

on

Novartis warns MFN could reshape European drug launches

on

ESMO: Imfinzi–Padcev shows promise with less Padcev after surgery

on

J&J’s oral RIPTAC shows early activity in advanced prostate cancer

on

Lycia Therapeutics closes upsized $365.1 million IPO

on

BMS reports death in MS CAR-T trial and aims to restart studies

on

Merck–Kelun ADC shows substantial progression-free survival benefit in PD-L1-negative NSCLC

on

Imdelltra–Imfinzi combination shows major survival benefit in Phase 3 lung cancer trial

on

Analysts warm to Merck–Moderna cancer vaccine after ESMO presentation

on

Pathos raises $237M and partners with BMS and Tempus on neuroscience AI

on

BMS reports a death in an MS CAR-T trial as it reviews inflammation signals

on

Amgen combination extends survival in small cell lung cancer trial

on

Innovent reports early Phase 2 results for IBI354 in first-line HER2-positive breast cancer

on